Overview
Neonatal hypoxic-ischemic brain injury, also known as hypoxic-ischemic encephalopathy (HIE) or neonatal hypoxic-ischemic encephalopathy, is a serious condition that occurs when a newborn's brain does not receive adequate oxygen and blood flow around the time of birth. This oxygen deprivation can result from events such as placental abruption, umbilical cord complications, uterine rupture, prolonged or obstructed labor, or severe maternal hypotension. The condition primarily affects the central nervous system, with the pattern and severity of brain injury depending on the duration and degree of the hypoxic-ischemic insult, as well as the gestational age of the infant. Clinical features vary based on severity and are often classified using the Sarnat staging system. Mild cases may present with irritability, hyperalertness, and mild changes in muscle tone. Moderate to severe cases can manifest with significant encephalopathy including seizures, depressed level of consciousness, abnormal tone (hypotonia or hypertonia), feeding difficulties, respiratory failure requiring ventilation, and multi-organ dysfunction affecting the kidneys, liver, and heart. Long-term neurological consequences may include cerebral palsy, intellectual disability, epilepsy, and visual or hearing impairment. The current standard of care for moderate to severe HIE is therapeutic hypothermia (cooling therapy), which involves reducing the infant's core body temperature to approximately 33.5°C for 72 hours, initiated within 6 hours of birth. This treatment has been shown to reduce mortality and improve neurodevelopmental outcomes. Supportive care includes management of seizures with anticonvulsant medications, maintenance of adequate ventilation and perfusion, correction of metabolic disturbances, and long-term neurodevelopmental follow-up. Research into adjunctive neuroprotective therapies, including erythropoietin and stem cell therapy, is ongoing.
Also known as:
Sporadic
Usually appears on its own, not inherited from a parent
Neonatal
Begins at or shortly after birth (first 4 weeks)
FDA & Trial Timeline
10 eventsAssistance Publique - Hôpitaux de Paris — PHASE2
Mahidol University — PHASE1, PHASE2
Cliniques universitaires Saint-Luc- Université Catholique de Louvain — NA
Healing Hope International
Assistance Publique - Hôpitaux de Paris
Boston Children's Hospital — PHASE1
Uludag University
Boston Children's Hospital
Mansoura University — PHASE4
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Neonatal hypoxic and ischemic brain injury.
20 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Neonatal hypoxic and ischemic brain injury.
Community
No community posts yet. Be the first to share your experience with Neonatal hypoxic and ischemic brain injury.
Start the conversation →Latest news about Neonatal hypoxic and ischemic brain injury
Disease timeline:
New recruiting trial: Stillbirth Risk Identification Using Multiparametric Ultrasound
A new clinical trial is recruiting patients for Neonatal hypoxic and ischemic brain injury
New recruiting trial: Cord Blood S100B Protein Concentration in Neonates With Fetal Growth Restriction
A new clinical trial is recruiting patients for Neonatal hypoxic and ischemic brain injury
New recruiting trial: Early Cessation of Sedation and TTM in Patients With a Favourable EEG After Cardiac Arrest
A new clinical trial is recruiting patients for Neonatal hypoxic and ischemic brain injury
New recruiting trial: Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)
A new clinical trial is recruiting patients for Neonatal hypoxic and ischemic brain injury
New recruiting trial: buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest
A new clinical trial is recruiting patients for Neonatal hypoxic and ischemic brain injury
New recruiting trial: Early WAKE-up Predictors After Out-of-Hospital Cardiac Arrest
A new clinical trial is recruiting patients for Neonatal hypoxic and ischemic brain injury
New recruiting trial: Predictors for Survival and Good Neurological Outcome in E-CPR and Non CPR Treated Patients
A new clinical trial is recruiting patients for Neonatal hypoxic and ischemic brain injury
New recruiting trial: Hypertonic Lactate After Cardiac Arrest
A new clinical trial is recruiting patients for Neonatal hypoxic and ischemic brain injury
New recruiting trial: Brain-injured Patients Extubation Readiness Study
A new clinical trial is recruiting patients for Neonatal hypoxic and ischemic brain injury
New recruiting trial: Role of Citicoline in Treatment of Neonates With Hypoxic Ischemic Encephalopathy
A new clinical trial is recruiting patients for Neonatal hypoxic and ischemic brain injury
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Neonatal hypoxic and ischemic brain injury
What is Neonatal hypoxic and ischemic brain injury?
Neonatal hypoxic-ischemic brain injury, also known as hypoxic-ischemic encephalopathy (HIE) or neonatal hypoxic-ischemic encephalopathy, is a serious condition that occurs when a newborn's brain does not receive adequate oxygen and blood flow around the time of birth. This oxygen deprivation can result from events such as placental abruption, umbilical cord complications, uterine rupture, prolonged or obstructed labor, or severe maternal hypotension. The condition primarily affects the central nervous system, with the pattern and severity of brain injury depending on the duration and degree of
How is Neonatal hypoxic and ischemic brain injury inherited?
Neonatal hypoxic and ischemic brain injury follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Neonatal hypoxic and ischemic brain injury typically begin?
Typical onset of Neonatal hypoxic and ischemic brain injury is neonatal. Age of onset can vary across affected individuals.
Are there clinical trials for Neonatal hypoxic and ischemic brain injury?
Yes — 20 recruiting clinical trials are currently listed for Neonatal hypoxic and ischemic brain injury on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Neonatal hypoxic and ischemic brain injury?
25 specialists and care centers treating Neonatal hypoxic and ischemic brain injury are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.